A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples